XML 102 R91.htm IDEA: XBRL DOCUMENT v3.25.3
SEGMENT INFORMATION - Narrative (Details) - Product Concentration Risk
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Revenue from Contract with Customer, Segment Benchmark | Xifaxan Branded Products | Salix    
Segment reporting information    
Concentration risk percentage 85.00%  
Revenues | Customer, Top Ten Products    
Segment reporting information    
Concentration risk percentage 50.00% 48.00%